About Kevin Ohashi
Form D filings for Akeso Biomedical from 2018 to 2023 list Kevin Ohashi as director.
Kevin Ohashi first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Ohashi in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Ohashi works with at each company, as listed on that company's latest Form D.
Akeso Biomedical, Inc. · Form D, Jun 6, 2023
GL
Greg Lee
Director
SW
Simon Williams
CEO and director
SR
Scott Roth
Director
RG
Robert Goforth
Director
AS
Anthony Sinskey
Director